An orally administered butyrate-releasing xylan derivative reduces inflammation in dextran sulphate sodium-induced murine colitis
Zhengqi Zha(China Pharmaceutical University), Hongping Yin(Hangzhou Normal University), Junwei Cheng(China Pharmaceutical University), Yinghua Miao(China Pharmaceutical University), Yanfang Tan(China Pharmaceutical University), Guoqing Wang(China Pharmaceutical University), Ying Wang(China Pharmaceutical University), Tingting Li(Sun Yat-sen University), Kang Ding(Nanjing University of Chinese Medicine), Xiao Xing(China Pharmaceutical University), Huiling Tang(Jiangsu Food and Pharmaceutical Science College), Yan Zhu(China Pharmaceutical University), Yang Lv(China Pharmaceutical University)
Cited by 105
Related Papers
Blood neuro‐exosomal synaptic proteins predict Alzheimer's disease at the asymptomatic stage
|Alzheimer s & Dementia|2020|256
Advances in the Development of Anti-Toxoplasma gondii Vaccines: Challenges, Opportunities, and Perspectives
|Trends in Parasitology|2019|197
Microbiota metabolism of intestinal amino acids impacts host nutrient homeostasis and physiology
|Cell Host & Microbe|2024|184